Ligan, Ronelyn L.

HRN: 03-55-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2023
CEFTRIAXONE 1G (VIAL)
02/18/2023
02/24/2023
IV
2g
OD
UTI
Waiting Final Action 
02/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/20/2023
02/26/2023
IV
500mg
Q8
Intraabdominal Infection
Waiting Final Action 
02/22/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/22/2023
02/28/2023
IVT
600mg
Q8
UTI
02/18/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/22/2023
02/28/2023
IV
1.5gram
Q6hrs
Acute Pyelonephritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: